BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 8 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $171,590 | -66.1% | 68,885 | -59.7% | 0.03% | -69.6% |
| Q1 2023 | $505,420 | -13.1% | 170,750 | -18.1% | 0.10% | -10.5% |
| Q4 2022 | $581,382 | -4.7% | 208,376 | -2.0% | 0.11% | -47.2% |
| Q3 2022 | $610,000 | +29.2% | 212,716 | +17.3% | 0.22% | +70.1% |
| Q2 2022 | $472,000 | -43.3% | 181,276 | +13.3% | 0.13% | -5.2% |
| Q1 2022 | $832,000 | +53.8% | 160,057 | +39.0% | 0.13% | +76.3% |
| Q4 2021 | $541,000 | -2.7% | 115,147 | -1.1% | 0.08% | -6.2% |
| Q3 2021 | $556,000 | +4954.5% | 116,446 | +1064.5% | 0.08% | +3950.0% |
| Q1 2021 | $11,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmond Asset Management, LLC | 75,000 | $180,000 | 0.06% |
| ARMISTICE CAPITAL, LLC | 375,000 | $926,250 | 0.01% |
| Sequoia Financial Advisors, LLC | 45,000 | $111,150 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 142 | $351 | 0.00% |